Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: Selected reports from working groups

Clinical Therapeutics

Volumn 30, Issue 11, 2008, Pages 2097-2101

  Giacoia, George P ^a   Taylor Zapata, Perdita ^a   Mattison, Donald ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

compounding; extemporaneous; National Institute of Child Health and Human Development; Pediatric Formulation Initiative; pediatrics

Indexed keywords

ARTICLE; CHILD CARE; DRUG EFFICACY; DRUG FORMULATION; DRUG RESEARCH; DRUG SAFETY; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; MEDICAL PRACTICE; NATIONAL HEALTH ORGANIZATION;

CHEMISTRY, PHARMACEUTICAL; CHILD; DOSAGE FORMS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG LABELING; FAMOUS PERSONS; HUMANS; NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (U.S.); PEDIATRICS; UNITED STATES;

EID: 57749207258     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.11.017     Document Type: Article

References (11)

1. Best Pharmaceuticals for Children Act, January 4, 2002 (Public Law No. 107-109). http://www.fda.gov/cder/pediatric/PL107-109.pdf Accessed November 18, 2008
2. Best Pharmaceuticals for Children Act, 2007 and Pediatric Research Equity Act of 2007 (Public Law No. 110-85). http://www.fda.gov/oc/initiatives/HR3580.pdf Accessed November 18, 2008
3. Giacoia G.P., Taylor-Zapata P., and Mattison D. Need for appropriate formulations for children: The NICHD Pediatric Formulations Initiative, Part 1. Int J Pharm Compound 11 (2007) 5-8
4. Giacoia G.P., Taylor-Zapata P., and Mattison D. Need for appropriate formulations for children: The NICHD Pediatric Formulations Initiative, Part 2. Int J Pharm Compound 11 (2007) 220-225
5. European Council Regulation on Medicinal Products for Pediatric Use (EEC) No. 1768/92, Directive 2001/83/EC and Regulation (EC) No. 716/2004. http://www.eaaci.net/site/content.php?artid=691 Accessed November 18, 2008
6. Michele T.M., Knorr B., Vadas E.B., and Reiss T.F. Safety of chewable tablets for children. J Asthma 39 (2002) 391-403
7. Schirm E., Tobi H., de Vries T.W., et al. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 92 (2003) 1486-1489
8. Pediatric Research Equity Act of 2003 (Public Law No. 108-155). http://www.fda.gov/cder/pediatric/index htm#prea. Accessed November 18, 2008
9. Beggs S.A., Cranswick N.E., and Reed M.D. Improving drug use for children in the developing world. Arch Dis Child 90 (2005) 1091-1093
10. Better medicines for children. Sixtieth World Health Assembly; May 23, 2007. WHA60.20. http://www.who.int/childmedicines/publications/WHA6020.pdf Accessed November 18, 2008
11. WHO Programmes and Projects. Make medicines child size. http://www.who.int/childmedicines/en/index.html Accessed November 18, 2008